Pharma-Bio Serv (PBSV) Change in Accured Expenses (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Change in Accured Expenses of -$148056.0 for Q1 2026, up 30.54% on a YoY basis from -$113421.5 in Q1 2025, and down 286.01% quarter-over-quarter from $79597.0 in Q4 2025.
Pharma-Bio Serv (PBSV) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Pharma-Bio Serv has reported Change in Accured Expenses for 17 years, with the latest figure at -$148056.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 30.54% year-over-year to -$148056.0; the trailing twelve-month figure through Jan 2026 stood at -$787921.0 (up 20.36% YoY), and the FY2025 full-year result was -$853006.0, up 29.35% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$148056.0, down from $79597.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $170854.0 in Q3 2023, with the low at -$597831.0 in Q2 2025.
- Historically, Change in Accured Expenses has averaged -$192035.3 across 5 years, with a median of -$174474.5 in 2023.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 305.27% — and 2024, when it slumped 1618.45%.
- Pharma-Bio Serv's Change in Accured Expenses stood at -$83385.0 in 2022, then tumbled by 285.47% to -$321427.0 in 2023, then jumped by 83.03% to -$54545.0 in 2024, then soared by 245.93% to $79597.0 in 2025, then slumped by 286.01% to -$148056.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$148056.0 (Q1 2026), $79597.0 (Q4 2025), and -$121631.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 8.92 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 11.03 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | -873,000.00 |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | -20.60 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | -35.25 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | -6.14 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | -9.67 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 49.11 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | -10.77 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -148,056.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -148,056.00 |
| Jan 31, 2026 | -148,056.00 |
| Oct 31, 2025 | 79,597.00 |
| Oct 31, 2025 | 79,597.00 |
| Jul 31, 2025 | -121,631.00 |
| Jul 31, 2025 | -121,631.00 |
| Apr 30, 2025 | -597,831.00 |
| Apr 30, 2025 | -597,831.00 |
| Jan 31, 2025 | -213,141.00 |
| Jan 31, 2025 | -213,141.00 |
| Oct 31, 2024 | -54,545.00 |
| Oct 31, 2024 | -54,545.00 |
| Jul 31, 2024 | -345,041.00 |
| Jul 31, 2024 | -345,041.00 |
| Apr 30, 2024 | -376,637.00 |
| Apr 30, 2024 | -376,637.00 |
| Jan 31, 2024 | -431,106.00 |
| Jan 31, 2024 | -431,106.00 |
| Oct 31, 2023 | -321,427.00 |
| Oct 31, 2023 | -321,427.00 |